Investor · Boston, MA
Michael J. Salsbury
Open Michael in the network graph →Filings
22
SEC Form D
Connections
100
co-filers
Capital
$41.0M
across filings
Active
Feb 2020
to Oct 2021
Most-connected co-filers (100)
Richard J. Kang · Boston, MA8 sharedJames P. Tursi · Princeton, NJ8 sharedJason J. Groves · Boston, MA7 sharedAkash J. Bakshi · Boston, MA6 sharedHyung H. Kim · Cambridge, MA5 sharedDarren Throop · Los Angeles, CA4 sharedD. Dividenz, Llc · Aventura, FL4 sharedIvan D. Chomer · CABA, C14 sharedHunter Walk · San Francisco, CA4 sharedJustin Hillenbrand · GREENWICH, CT4 sharedD. Dividenz, Llc · Aventura, FL4 sharedDaniel Collin · GREENWICH, CT4 sharedEzequiel D. Chomer · CABA, C14 sharedGeneral Partner of the General Partner Charlesbank Credit Opportunities Fund III GP, LLC · Boston, MA4 sharedSimon Katz · Los Angeles, CA4 sharedIan Estaphan Owen · Bristol, RI4 sharedMichael Gaubert · Dallas, TX3 sharedChet M. Kaczor · DENVER, CO3 sharedPatrick G. Sakala · Grand Cayman, Cayman Islands3 sharedJoseph W. Bagan · Denver, CO3 sharedStephen M. Davis · DENVER, CO3 sharedMatthew Schaefer · Chicago, IL3 sharedJonathan R. Ezrow · New York, NY3 sharedMark M. Spiecker · DENVER, CO3 shared
Recent filings (22)
Dividenz SPV 9 LLCOct 2025 · 7 co-filers$1.4MDIVIDENZ SPV 10 LLCOct 2025 · 7 co-filers$2.9MMetaVia Inc.May 2025 · 23 co-filers$10.0MMetaVia Inc.May 2025 · 23 co-filers$10.0MSHENANDOAH ENERGY PARTNERS III, LLCMay 2025 · 10 co-filers$100.0MSHENANDOAH ENERGY PARTNERS II, LLCJul 2024 · 10 co-filers$75.0MNeuroBo Pharmaceuticals, Inc.Jul 2024 · 23 co-filers$17.0MNeuroBo Pharmaceuticals, Inc.Jul 2024 · 23 co-filers$17.0MDividenz SPV 9 LLCApr 2023 · 7 co-filers$1.4MCabral Gold Inc.Apr 2023 · 17 co-filers$3.2MDIVIDENZ SPV 10 LLCMar 2023 · 7 co-filers$2.9MCabral Gold Inc.Mar 2023 · 17 co-filers$1.9MNeuroBo Pharmaceuticals, Inc.Oct 2021 · 21 co-filers$14.0MNeuroBo Pharmaceuticals, Inc.Oct 2021 · 21 co-filers$14.0MMonomoy Capital Partners IV Parallel, L.P.Apr 2021 · 5 co-filers$1.0BMonomoy Capital Partners IV, L.P.Apr 2021 · 5 co-filers$1.0BHyver Labs, LLCApr 2021 · 5 co-filers$1.0MSTAQ Pharma, Inc.Mar 2021 · 26 co-filers$9.0MMonomoy Capital Partners IV, L.P.Feb 2021 · 5 co-filers$1.0BMonomoy Capital Partners IV Parallel, L.P.Feb 2021 · 5 co-filers$1.0BNeuroBo Pharmaceuticals, Inc.Feb 2021 · 23 co-filers$10.0MNeuroBo Pharmaceuticals, Inc.Feb 2021 · 23 co-filers$10.0MNeuroBo Pharmaceuticals, Inc.Jan 2021 · 27 co-filers$17.0MNeuroBo Pharmaceuticals, Inc.Jan 2021 · 27 co-filers$17.0MSTAQ Pharma, Inc.Apr 2020 · 26 co-filers$9.0M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Michael in the interactive graph →